Insilico identifies therapeutic targets implicated in aging using AI and hallmarks of aging framework
People worldwide are living longer. According to WHO, one in six people in the world will be aged 60 years or over by 2030. However, aging increases vulnerability to a wide range of human disorders, including cancers, diabetes, cardiovascular diseases and neurodegenerative diseases. Roughly two-thirds of the 150,000 people who die each day globally suffer from age-associated diseases.
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that it has successfully established a unique approach to identify potential dual-purpose therapeutic targets of aging and age-associated diseases with PandaOmics, its proprietary AI-enabled biological target discovery platform.
Learn about our two Decals!
Click here to find out more about our Fall Bioinspired Design Decal and our Spring Bioinspired Design in Action Decal – ALL MAJORS are welcome.
Berkeley BioDesign Community
Click here to learn about the BioD: Bio-Inspired Design @ Berkeley student organization or here to signup for more info.
Search
Student Login
I imagine that the neurological circuits underlying these processes are governed by both 2d spacing maps with their brains as…
to reduce the impact of car accidents, it may be possible to study the force diverting physics of cockroaches to…
you see this type of head-bobbing stability in many avian creatures related to pigeons like chickens. the head ability to…
not like they taught horses how to run! this is an example of convergent evolution where both sea creatures and…
The brain functions in a similar way with neuronal connections. our brains are able to utilize the multiplicity of connections…